Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors.

Sunaga N, Hasegawa Y, Sato M

Open source

DOI
10.1002/resp.70315
Published
2026 Sep 16
Container
Respirology (Carlton, Vic.)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/resp.70315,
  title = {Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors.},
  author = {Sunaga N and Hasegawa Y and Sato M},
  year = {2026},
  journal = {Respirology (Carlton, Vic.)},
  doi = {10.1002/resp.70315},
  url = {https://doi.org/10.1002/resp.70315}
}

RIS

TY  - JOUR
TI  - Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors.
AU  - Sunaga N
AU  - Hasegawa Y
AU  - Sato M
PY  - 2026
JO  - Respirology (Carlton, Vic.)
DO  - 10.1002/resp.70315
UR  - https://doi.org/10.1002/resp.70315
ER  - 

APA

N, S., Y, H., & M, S. (2026). Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors.. Respirology (Carlton, Vic.). https://doi.org/10.1002/resp.70315

Source records